Breath tests cover the fraction of nitric oxide in expired gas (F ENO ), volatile organic compounds
(VOCs), variables in exhaled breath condensate (EBC) and other measurements. For …

… as a promising source of biomarkers of lung diseases. Substances measured in EBC …
Although EBC has great potential as a source of biomarkers in many lung diseases, the low …

… to several lung diseases, such as chronic obstructive pulmonary disease (COPD) and lung
… and the respiratory epithelium of both these diseases express altered miRNA profiles. …

… , as biomarkers. This review focuses on the validation of VOCs as novel biomarkers for …
growing rapidly, this may expedite the development of VOCs as biomarkers in lung disease. …

… biomarkers reflect improvement of bleomycin-induced lung … in biomarkers associated with
lung disease, we quantified lung … slowly progressing mouse models of fungal lung infection. …

… diseases. Establishment of enzyme-linked immunosorbent … application of lung collectins
as biomarkers in addition to the … now clinically used as biomarkers for lung diseases. Various …

… study biomarkers of lung disease within the ’omics field. The contributions of the individual
’omics analytical platforms to the field of respiratory diseases … -based studies of lung disease. …

… In conclusion, the clinical need for a biomarker in diffuse lung disease regarding the
presence or absence of the disease, the histospecific diagnosis and the prediction of …

… This article reviews major biomarkers in serum and … connective tissue disease–associated
interstitial lung disease (CTD-… discovery and validation of biomarkers for diagnosis, prognosis, …

… lung disease and their capacity to act as shuttles to deliver therapeutics (30) that differentiate
them from other canonical biomarkers. … assessment of MPs as a biomarker in lung disease. …